Impax Pharmaceuticals Announce FDA Approval of Rytary (carbidopa and levodopa) for Parkinson’s Disease

HAYWARD, Calif., Jan. 8, 2015 /PRNewswire/ — Impax Pharmaceuticals, a division of Impax Laboratories, Inc. (NASDAQ: IPXL), today announced that the U.S. Food and Drug Administration (FDA) approved Rytary, an extended-release oral capsule… – New Drug Approvals

Pharmaceutical Stocks


© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us